Reports of dCA in patients with ICH group are scarce, yet diverse. In a case-control study, a higher gain was observed within 3 days of ICH onset when compared with the healthy controls, indicating a less effective dCA during the acute stage.
S
pontaneous intracerebral hemorrhage (ICH) is a devastating cerebral vascular disease with both high morbidity and mortality. Lowering blood pressure at an early stage of ICH may help in preventing hematoma expansion and improving clinical outcomes, however, with the risk of hypoperfusion and secondary brain injury. 1 Cerebral autoregulation (CA), a mechanism that protects the brain tissue from either hyperperfusion or hypoperfusion within a wide range of blood pressure fluctuations, 2 is thus of great concern for patients with ICH. Impaired CA may lead to passive changes of cerebral blood flow in response to the fluctuations of blood pressure, in which case the metabolic needs of tissue may not be satisfied if blood pressure level cannot be properly maintained. Therefore, characterizing CA after ICH may fundamentally improve blood pressure management.
Previous studies [3] [4] [5] applied the concept of static CA, which focuses on the baseline alteration of cerebral blood flow in ICH patients before and after the use of different strategies of blood pressure reduction to determine whether CA is preserved. With the advent of transcranial Doppler ultrasonography and techniques of noninvasive continuous blood pressure measurement, the high temporal resolution recordings of blood flow velocity and blood pressure allow for the assessment of dynamic cerebral autoregulation (dCA) from the responses of blood flow to instantaneous changes of blood pressure. 6 Different from static CA, 2, 6, 7 dCA is more sensitive to the pathological situations 8, 9 and has been demonstrated to change over the time course of ischemic stroke.
after ictus, whereas a higher gain value was not associated with any clinical factors or outcome.
14 Serial index Mx (reflecting both static and dynamic CA) was also derived within 5 days after ICH onset. Although it was not generally impaired on the first day, a secondary decline between days 3 and 5 could possibly occur mainly on the affected side, and this may be associated with poorer clinical status and outcomes. 15 Yet, the above studies all garnered attention toward the early stage after ICH, while ignoring the subacute and recovery stages. This left unresolved whether, when, and to what extent could the altered dCA be restored.
Thus, in the present study, we sought to (1) investigate the time course of dCA in ICH patients with serial follow-ups, including 1 to 2 days after ictus and 3 additional time points within a month, and (2) explore the correlation of autoregulatory parameters at different time points with clinical characteristics, as well as the outcomes.
Methods

Subjects and Controls
In this prospective study, we enrolled consecutive ICH patients who were admitted to the Department of Neurology, First Hospital of Jinlin University, China, in June 2014 to February 2015. The patients were included in our study if they met the following criteria: (1) admission time <24 hours post ictus; (2) supratentorial hemorrhage was present; (3) Glasgow Coma Scale (GCS) score of >8 points on admission, as assessed by an experienced neurologist; and (4) sufficient bilateral temporal bone windows for insonation of the middle cerebral artery. Additional exclusion criteria included the following: (1) undergoing any surgical treatments, including ventricular drainage, clot removal, and craniotomies while hospitalization; (2) middle cerebral artery or other intracranial and extracranial major vascular stenosis/ occlusion, as diagnosed by a transcranial Doppler (MultiDop X2, DWL, Sipplingen, Germany) and carotid ultrasound (IU22, Phillips, Andover, MA); (3) having a prior symptomatic cerebral vascular disease; (4) current arrhythmia, hyperthyroidism, anemia, and unstable blood pressure, which may undermine hemodynamic stability; and (5) intolerant of dCA measurements. Consents were obtained from subjects or their direct relatives, and the informed consents were signed before beginning the study. The subjects had the right to withdraw at any time point of our procedure. The study was approved by Ethics Committee of the First Hospital of Jilin University, China.
Reference values of the study were obtained from 30 age-and sex-matched nonsmoking healthy controls (52.3±8.1 years, 21 men) through bilateral middle cerebral artery measurement, and 60 sets of dCA parameters were used overall for statistical analysis, regardless of hemisphere.
Clinical Data
All subjects received routine monitoring of vital signs and intensive nursing care in the stroke unit. The management of blood pressure and glucose was in accordance with current ICH management guidelines. 16 The National Institutes of Health Stroke Scale (NIHSS) was administered on admission and discharge. GCS was assessed at each time point except the measurement on day 30. A standard oral history and laboratory results were recorded to determine cerebrovascular risk factors, which included records of hypertension, diabetes mellitus, hyperlipidemia, smoking, and excessive drinking. Details of the medications administered to patients in hospital were also recorded. Clinical outcome was assessed using the modified Rankin Scale 90 days after ictus via a telephone interview with subjects or their relatives by an examiner who was blinded to autoregulation results.
Hematoma location and volume were determined from the computed tomography (64-slice, Somatom Definition; Siemens Healthcare, Germany) scan on admission for each subject by a neuroradiologist blind to the clinical and hemodynamic data. For regular hematoma, ICH volume was calculated using the length*width*depth/2 formula; for irregular hematoma, the length*width*depth/3 method was adopted. 17 Although hospitalized, 38 of 43 subjects underwent an additional 1 or 2 computed tomography scans according to their clinical status, as determined by a neurologist at different time points. We did not use those data because of a potential selection bias.
dCA Measurements
Serial measurements of dCA were performed at 4 time points, 1 to 2 days (usually on admission), 4 to 6 days, 10 to 12 days (usually on discharge), and 30 days after ICH onset for each subject. All measurements were performed in a quiet, dedicated examination room with surrounding stimuli minimized. The subjects were told to breathe normally in a supine position for 5 minutes before measurements. Baseline blood pressure was measured at the brachial artery (automatic blood pressure monitor, Omron 711). Continuous cerebral blood flow velocities (CBFV) were assessed noninvasively using transcranial Doppler. Bilateral middle cerebral artery was probed at a depth of 45 to 60 mm with 2 MHz probes attached to a custommade head frame. Spontaneous arterial blood pressure (ABP) was simultaneously recorded using a servo-controlled plethysmograph (Finometer Pro, Netherlands) on the left or right middle finger with an appropriate finger cuff size. Endtidal CO 2 was measured using a capnograph (MultiDop X2, DWL, Sipplingen, Germany) with a face mask attached to the nasal cannula. Data were recorded for over 10 minutes until a stable recording was established. The recorded data were stored for further dCA analysis.
Data Analysis
The dCA analysis of the clinical data was performed blindly for each subject. The recorded data were processed on a personal computer using MATLAB (MathWorks, Natick, MA). To eliminate the possible time lags, beat-to-beat alignment of the data was achieved with a cross-correlation function. A third-order Butterworth low-pass filter (cutoff at 0.5 Hz) was applied as an anti-alias filter before downsampling the data to 1 Hz. The relationship between dynamic changes in ABP and CBFV was assessed with a transfer function analysis, 18 which quantifies the extent to which the input signal (ABP) is reflected in the output signal (CBFV). A transfer function was used to calculate the quotient of the cross-spectrum of ABP and CBFV signals and the autospectrum of ABP in the frequency domain. Impulse and frequency responses are derived from transfer function analysis.
Autoregulation parameters were derived for both the time and frequency domains to quantify dCA. In the time domain, the step response of CBFV shows the recovery of cerebral blood flow if a stepwise change in ABP was occurred. To quantify the speed of recovery, we defined the rate of recovery (RoRc) of CBFV as ∆CBFV/∆t×100%, where the first 3 s were used for calculation. In the frequency domain, we estimated and then averaged the phase difference (PD), gain, and coherence within a low frequency range (0.06-0.12 Hz), where the derived parameters were considered most relevant to autoregulation hemodynamics. 19 Autoregulatory parameters were adopted for later statistical analysis only if the coherence was >0.49 within 0.06 to 0.12 Hz.
Statistical Analysis
Data were analyzed using the Statistical Program for Social Sciences version 21.0 (SPSS; IBM, West Grove, PA). Continuous data are expressed as the mean and standard deviation; discrete variables are expressed as absolute values and percentages. The Shapiro-Wilk test was used to test for normal distribution of continuous variables. For normally distributed data, intraindividual differences in autoregulatory parameters between the affected and unaffected hemispheres were compared using a paired t test. Analysis of variance was used to compare autoregulatory parameters between different time course measurements and controls. A least significance difference method was used for post hoc analysis. Univariate linear regression was applied to explore by guest on November 17, 2017 http://stroke.ahajournals.org/ Downloaded from the correlation of absolute value of PD and gain with clinical factors, including ICH volume, mean ABP and GCS, and NIHSS on admission and discharge. Furthermore, a multivariate linear regression was used to assess the association of dCA parameters and clinical factors with the modified Rankin Scale at 90 days, whereby dCA parameters at different time points were involved in respective models. Calculated 2-tailed P values <0.05 were considered statistically significant.
Results
In the current study, we enrolled 43 patients and performed a total of 121 measurements successfully, among which 10 measurements could not be used (signal artifacts, n=4; low coherence of transfer function analysis, n=6). The demographic and baseline characteristics of included patients are presented in Table 1 . Hemodynamic and dCA parameters of serial measurements in ICH patients and the reference value are presented in Table 2 and Figure 1 . Graphic results of the PD and the slope of the step response are shown in Figure 2 .
Phase Difference
Overall, PD did not differ between affected and unaffected hemispheres of ICH patients across all study time points (days 1-2, P=0.291; days 4-6, P=0.537; days 10-12, P=0.662, and day 30, P=0.625). A significant decrease in PD was found in both affected and unaffected hemispheres during the first 3 measurements (all P<0.001), followed by a nearly complete recovery on day 30 compared with controls (all P>0.05). The absolute value of bilateral PD reached the nadir on days 10 to 12 ( Table 2 and Figures 1A and 2A and 2B ).
Gain
Gain did not significantly differ between the affected and unaffected hemispheres of ICH across all study time points, with the exception of measurements that were obtained on days 1 to 2 (days 1-2, P=0.002; days 4-6, P=0.904; days 10-12, P=0.110; and day 30, P=0.859). Although higher in absolute value of bilateral gain across all measurements, there was no statistical significance in affected hemisphere gain between measurements and controls (P=0.115). In the unaffected hemisphere, a significantly higher gain was observed in the first 2 measurements (days 1-2, P=0.003; days 4-6, P=0.02), when compared with the controls (Table 2 and Figure 1B ).
Step Response and the Rate of Recovery of CBFV
Bilateral step responses at each time point in the ICH patients and the healthy controls are depicted in Figure 2C and 2D.
Step response shows how quickly CBFV can return to a baseline level in response to a unit change of ABP. In the healthy controls, it takes ≈4 s for CBFV to return to the baseline, whereas it does not return to the baseline level, bilaterally, in the patients with ICH at all time points, indicating impairment of dCA ( Figure 2C and 2D) . RoRc of CBFV derived from step response was calculated to quantify the extent of the impairment. This autoregulatory parameter did not differentiate the affected hemispheres from the unaffected at all time points except the measurement on day 30 (days 1-2, P=0.904; days 4-6, P=0.364; days 10-12, P=0.260; and day 30, P=0.010). Significant decreased RoRc of CBFV was found for both the affected and unaffected hemispheres for the first 3 measurements, when compared with the controls (all P<0.05), and then increased to the reference level on day 30 (affected hemisphere, P=0.118; unaffected hemisphere, P=0.789). This is in accordance with PD changes measured over the temporal course including that bilateral values also reached lowest point on days 10 to 12 (Table 2 and Figure 1C ).
dCA Parameters, Clinical Factors, and Outcome Table 3 shows the clinical factors that are significantly related to PD and gain at different time points, as revealed by a univariate analysis. As for PD, lower bilateral PD was associated with poorer GCS on days 1 to 2. Lower affected hemisphere PD on days 4 to 6 was associated with poorer NIHSS on discharge. In terms of gain, higher value of gain was significantly correlated with larger ICH volume and poorer NIHSS on admission/discharge only on days 10 to 12. Mean ABP was associated with both the affected-side PD on days 1 to 2 and the affected-side gain on days 4 to 6.
Two significant models of multivariate regression analysis are displayed in Table 4 . When dCA parameters on days 1 to 2 were involved (Model 1), NIHSS on admission and ICH volume were significant in predicting 90-day outcomes, whereas affected-side PD approached significance (P=0.057). When dCA parameters on days 4 to 6 were considered (Model 2), NIHSS on admission and affected-side PD remained the independent predictive values for 90-day outcomes.
Discussion
To the best of our knowledge, this is the first study that focused on the evolution of dCA after ICH onset with multiple follow-up measurements in 1 month. The results mainly suggest that in acute ICH patients, dCA is bilaterally impaired for at least 10 to 12 days and can recover within a month. Thus, meticulous blood pressure management during the time of dysautoregulation may be worth further consideration. Additionally, lower individual PD in acute-stage measurements is correlated with poorer clinical status. Furthermore, the affected side PD on days 4 to 6 is an independent predictor for the 90-day clinical outcomes after ICH. In 2 previous studies, transfer function analysis was performed to derive dCA parameters in ICH group. 7, 14 Presumably, with relatively small sample sizes, neither of these 2 studies found a significant difference of the autoregulatory parameters between the ICH patients and healthy controls, although the results of these studies clearly demonstrated that PD tended to decrease at low frequency. We, therefore, increased the sample size and found that the bilateral PD results were consistent with the aforementioned trend but significantly decreased when compared with the controls. Higher gain was reported than healthy controls in these 2 studies, which indicates an impaired damping effect of cerebral blood flow. Oeinck et al suggested that higher gain was not related to any clinical factors or outcomes, but Nakagawa et al noted an association between a higher gain value and larger ICH volume within 3 days post ictus. The value of gain in our cohort is universally higher than the reference value from the first measurement onward, which is consistent with 2 previous studies, but shows significance in the unaffected hemisphere within the first 2 measurements. With further regression analysis, it is interesting to note that we found close correlations between several clinical factors and gain mostly on days 10 to 12 but not at other time points. Transfer function gain, however, was fickle 
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in varied pathophysiological conditions, and the interpretation of gain was divergent. 20 Even though all of the 3 parameters that were derived in our study revealed an impaired autoregulation to varying degrees, gain does not manifest a clear trend across time points. We thus do not consider gain as a specific parameter to quantify the changes of dCA in this type of pathological status. Furthermore, none of the previous studies derived parameters in time domain for ICH. We applied RoRc of CBFV, quantifying how fast the CBFV could respond after a blood pressure change. Similar to PD, RoRc of CBFV also suggests a bilateral decline and late recovery, which strengthens the findings by PD.
Only few previous serial measurements addressed the time course of dCA in patients with acute ICH. Reinhard et al and Oeinck et al, respectively, applied different indexes to quantify CA focusing on the same ICH group on days 1, 3, and 5 after ictus. 14, 15 A correlation coefficient index (Mx) revealed that CA was primarily preserved at the acute stage but possibly compromised on days 3 to 5 after ICH on the affected hemisphere, and this may be associated with poor clinical Step response of all time points in ICH patients and controls on affected and unaffected hemispheres. In healthy controls, it takes ≈4 s for cerebral blood flow velocity (CBFV) to return to baseline if induced by a unit change of arterial blood pressure, but ICH patients at different time points could not return bilaterally as fast as healthy controls. D1-2 indicates days 1 to 2; D4-6, days 4 to 6; D10-12, days 10 to 12; D30, day 30. ABP indicates arterial blood pressure; D1-2, days 1-2; D4-6, days 4-6; D10-12, days 10-12; dCA, dynamic cerebral autoregulation; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; NIHSS, National Institutes of Health Stroke Scale; and PD, phase difference.
by guest on November 17, 2017 http://stroke.ahajournals.org/ Downloaded from outcomes. Comparable autoregulatory parameters were also derived from transfer function analysis at the same time points; however, such secondary deterioration of CA was not shown either by phase or gain. Within 7 days of serial measurements, Schramm et al demonstrated that both dynamic and static CA were impaired after severe brain injury and that ICH patients with a nadir on day 4 subsequently experienced an incomplete recovery over time. 21 Yet, with a study length of 1 month, we found a prolonged impairment of dCA for at least 10 to 12 days post ictus. Moreover, PD and RoRc values indicated the worst autoregulation at that time point. This result might suggest that a possibility of more sustained and apparent autoregulatory deterioration could happen on 10 to 12 days post ICH onset, which is beyond the time course of previous reports. With autoregulation absent, the brain tissue may be particularly vulnerable to clinical blood pressure fluctuations. Aggressive lowering of blood pressure would increase the risk of sudden hypoperfusion and even acute infarcts, whereas a large elevation of blood pressure could initiate vasospasm in proximal cerebral arteries, where the distal small vessels may fail to compensate for these cerebral blood flow changes.
Thus, we speculated that impaired autoregulation may serve as one of the etiologies of acute brain infarcts that were detected by diffusion-weighted imaging in ICH patients. 22, 23 Therefore, careful blood pressure monitoring and management can be critical for preventing secondary injury after ICH.
The mechanism underlying the characteristics of impaired dCA in ICH patients remains unknown. Undoubtedly, the pathophysiology of ICH may also involve mechanisms that directly hamper autoregulation, for example, increased intracranial pressure, 24 inflammation response, 25 and edema formation. 24, 25 In a pilot study, an invasive assessment was applied to examine autoregulation and brain metabolism in the perihematomal zone of ICH, and a local disturbed autoregulation in edema was recorded. 26 Although the hematoma remained stable or was absorbed in the following days, the perihematomal edema always reaches its maximum between 10 and 20 days after ictus, 27 which may explain the more evident autoregulatory dysfunction on days 10 to 12 in our study. We also note that dCA parameters are suggestive of a bilateral change across the whole study. In most cases, we recorded a mild to moderate volume in ICH patients; thus, it is not likely that intracranial pressure is elevated to affect global cerebral perfusion and compromise bilateral CA. Interestingly, bilateral impairment of dCA was also found in patients with ischemic stroke, particularly at the acute and subacute stages, 9,10,12 even in patients with mild ischemic stroke. 13 This global deteriorative autoregulation may be explained by a vicious cycle that begins within the peri-infarct region that includes initial lactate acidosis accumulation, reperfusion, production of inflammatory vasotoxic substances, dysautoregulation, edema, and further ischemia. 28 We speculated that these pathophysiological mechanisms may also exist in the peri-hemotoma region and eventually worsen global autoregulation. Moreover, ICH, mostly as a result from rupture of small vessels, has longterm structural changes in cerebral small vessels caused by chronic hypertension or other multiple vascular risk factors. Although dCA parameters on day 30 indicate that CA are not significantly different from the healthy controls, it is, however, not fully recovered by then, possibly reflecting a preexisting dysfunction of dCA before ICH because of endothelial dysfunction caused by small vessel diseases. After a sudden brain insult, this underlying dysfunction would be additionally exacerbated, depending on the reserved autoregulatory capability. However, in the present study, we could not identify cerebral microbleeds, lacunar infarcts, or white matter lesions because those pathological changes could not be easily detected using computed tomography scans. Nevertheless, these pathologies have already been associated with an impaired CA or cerebrovascular reactivity. [29] [30] [31] The relationship between the autoregulation parameters and clinical factors as well as outcomes has been reported by previous studies. 7, 14, 15 Using a multivariate analysis, Reinhard et al indicated that poorer autoregulation (assessed by Index Mx) on day 5 was an independent predictor of poor clinical outcome if other hemodynamic variables were controlled. 15 Similar results in our study demonstrated that affected-side PD on days 4 to 6 after ICH is an independent predictor for the 90-day clinical outcome, although minimum PD and Two multivariate regression models are shown considering different time course of autoregulatory parameters. ABP indicates arterial blood pressure; D1-2, days 1-2; D4-6, days 4-6; dCA, dynamic cerebral autoregulation; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; mRS, the modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and PD, phase difference. by guest on November 17, 2017 http://stroke.ahajournals.org/
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RoRc of CBFV were found on days 10 to 12. Thus, further work is required to understand the role of autoregulation at this time point and to investigate how it could be improved. Furthermore, Oeinck et al reported that there was a significant association between lower ABP and poorer autoregulation on the affected side on day 1, 14 whereas in our study, a higher ABP is associated with poorer autoregulation during the first 2 measurements (PD on day 1-2, gain on day 4-6). This disagreement can be explained by the higher ABP in our cohort (≈15 mm Hg higher in averaged mean ABP) because the proportional relationship that was reported by Oeinck et al was only notable with a mean ABP that is below 100 mm Hg. We speculate that either elevating or lowering ABP might cause a detrimental effect on dCA in acute ICH, and thus, an optimal blood pressure level may exist in terms of dynamic autoregulatory capability.
The present study has following limitations. We only selected ICH patients with mild to moderate volume and a GCS of >8 points at admission because these patients could well cooperate with our study protocol, and there was no need to monitor the intracranial pressure in these patients. Thus, we directly use ABP instead of cerebral perfusion pressure to calculate dCA parameters, ignoring changes in intracranial pressure. As a result, our conclusions may not apply to patients with severe ICH. Given the preliminary nature of this work, the most significant issue concerning ICH, whether a reduction of blood pressure at the acute stage would exacerbate dCA, could not be answered. Subsequent well-designed self-control studies targeting various blood pressure reduction levels are urgently needed for providing reliable information for optimal blood pressure management.
Conclusions
The current study demonstrates that in mild to moderate supratentorial ICH patients, dCA is bilaterally impaired at acute stage and lasts for at least 10 to 12 days, followed by a substantial recovery by day 30. The individual PD value is associated with clinical status at acute stage, and PD at the affected hemisphere on days 4 to 6 can be an independent predictor for clinical outcome.
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